HD-OPM Archive
Topics › Statins

Case for over-the-counter statins: 22% lower risk per 1 mmol/L LDL drop

Louis Nervegna · May 19, 2025 · ♥ 16 reactions · 3 comments · original Facebook post
StatinsGuidelines, policy & public healthLDL, ApoB & lipid panel
AI summary & key facts

Louis quotes an essay urging OTC statins: CTT meta-analysis shows 22% fewer MI/stroke per 1 mmol/L LDL reduction, with serious muscle injury rare. He includes his math that 1.3 million users could avert about 14,000 events.

Quoted:

“Every 1 mmol/L [40 mg/dL], that low-density lipoprotein is forced downward chops the risk of myocardial infarction or stroke by roughly 22 percent [over 5 years]—the conclusion of the Cholesterol Treatment Trialists’ 170 000-patient meta-analysis.”

“Mother Nature herself runs a permanent, double-blind trial: people born with loss-of-function variants in PCSK9 or ANGPTL3 cruise through life with LDLs in the 20–40 mg/dL range and enjoy 30-plus-percent cuts in coronary risk without obvious downside (1, 2, 3, 4).”

“Serious muscle injury from statins occurs in <0.1% of users; hepatotoxicity is an order of magnitude rarer [0.01%].”

“Say only one percent of the 130 million U.S. adults aged 40-75 grab an OTC statin. That is 1.3 million new users. Apply the CTT risk curve to a conservative 10-year ASCVD baseline of 5 percent and you avert ~14,000 heart attacks and strokes. Value each event at a (ludicrously low) 4 QALYs and you are buying 56,000 quality-adjusted life-years for pocket change.”

[Here’s the math on that last one: In a 10 year period, 5% out of 1.3M people ages 40-75yo in the USA would be expected to have a heart attack or stroke. That is 65,000 people. A low dose statin which reduces LDL by just 40 mg/dL would save 22% of those people over 5 years, meaning avoidance of at least 14,000 heart attacks and strokes. Higher doses would save even more. That 22% figure comes from the Cholesterol Treatment Trialists (CTT) meta-analysis previously quoted.]

“If critics whip out the organic-purist card, remind them that lovastatin was literally purified from red-yeast-rice mold. Statins are fermented corn, just tidied up by medicinal chemistry. The FDA currently bans supplement makers from leaving the active monacolin K fraction in their red-yeast-rice capsules; your deregulatory pen could fix that contradiction overnight.”

alexkesin.comMr. Secretary, Reclassify the StatinOne regulatory stroke could save more American lives than a decade of health campaigns. You have the pen.alexkesin.com

#statinrctsHD #myalgiaHD #mendelianrandomizationHD #mrHD #statinsmrHD #ldlmrHD

Research cited

← newer: Meta-analysis of 4 RCTs: Mediterranean diet cut MACE 48% andolder: Hysterectomy before 50 linked to higher CVD risk in Nurses' →